Insulet estimates that the pods involved in this correction represent approximately 1.5% of annual production globally.

The FDA approved a new Lantheus prostate cancer imaging agent. South Carolina's measles cases rise. Medtronic's MiniMed shares drop in Nasdaq debut. A French probe exonerates Nestle in a baby death ...

DexCom is also increasingly targeting non-diabetic patients, notably with newer over-the-counter products in the U.S. such as Stelo, which received clearance in 2024 and has attracted over half a ...

Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

The Citizens Life Sciences Conference 2026 March 11, 2026 1:05 PM EDTCompany ParticipantsDavid Pacitti - CEO & ...

Stratasys Ltd. ( SSYS) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST ...

Medtronic and GE HealthCare inked a multiyear deal to expand their more than three-decade- long partnership that aims to boost clinical and technology innovation.

Medtronic (NYSE:MDT) has entered a definitive agreement to acquire Scientia Vascular, a maker of neurovascular access devices ...

Intuitive's latest executive pay disclosure also reported higher pay for its average worker and said one leader would soon be ...

Medtronic has been hiking its dividend for nearly 50 consecutive years. It's spinning off its diabetes division to focus on faster-growing businesses. Its strategy makes sense -- and its valuation is ...

The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause ...

Shares drop 2.6% despite beating quarterly expectations Company expects $300 million hit from tariffs in fiscal 2027 CEO says Danaher-Masimo deal will not change patient-monitoring market long term ...